Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

15.90
BATS BZX Real-Time Price
As of 3:24pm ET
 +0.05 / +0.32%
Today’s Change
2.85
Today|||52-Week Range
18.40
+421.31%
Year-to-Date
5 Health Care Stocks Gurus Are Buying
Dec 07 / GuruFocus News - Paid Partner Content
4 Biotech Stocks to Better Your Financial Health This Winter
Dec 01 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics, Akebia...
Dec 06 / Zacks.com - Paid Partner Content
Is GW Pharma (GWPH) Likely to Beat Earnings Estimates in Q4?
Nov 30 / Zacks.com - Paid Partner Content
5 Top-Ranked Drug Stocks that are Broker Favorites
Dec 05 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close15.85
Today’s open16.05
Day’s range15.65 - 16.20
Volume53,343
Average volume (3 months)1,683,123
Market cap$1.3B
Data as of 3:24pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)+29.09%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book8.25

Competitors

----
EPZMEpizyme Inc-0.15-1.17%
RTRXRetrophin Inc+0.33+1.59%
FPRXFive Prime Therapeut...-1.23-5.21%
Data as of 3:24pm ET, 12/12/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts